- The Nasdaq closed 0.93% lower at 14,656 on Tuesday.
- Monday.com soared 24% on strong Q2 results including 94% revenue hike.
- Moderna rallied 7.5% on news the U.K. approved its COVID jab for ages 12-17.
The US markets closed lower on Tuesday as a weaker than expected retail sales report for July was released and investor sentiment was dampened by the growing geopolitical tension in Afghanistan.
The Dow Jones fell 0.79% to finish the trading day down 282 points to close at 35,343 points .
The tech heavy NASDAQ fell 0.93% to finish the trading day down 138 points to close at 14,656 points.
One bitcoin is worth US$44,691 going into the Asian trading day.
The Australian dollar is stronger against the major currencies and is buying 72.58 US cents.
Shares in recent Wall St debutant Monday.com skyrocketed 24% yesterday after the business management software provider released strong second-quarter results. For the period, Monday.com reported a 94% increase in revenue YoY to US$70.6m, and an operating loss of US$9.9m compared to a US$14.9m loss in the corresponding quarter a year earlier.
U.S.-biotech company Moderna soared more than 7% on Tuesday after its COVID-19 vaccine was approved by health officials in the U.K. for children aged 12-17. US authorities are also reportedly planning to authorise booster shots for most Americans, allowing those who have received two doses of Moderna or Pfizer to receive a third, eight months later.
And Twitter is testing a new feature allowing users to report ?misleading? tweets to prevent misinformation on topics like politics and health from spreading.